Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose-regulated protein 75 (GRP75), also known as Mortalin or heat shock 70 kDa protein 9 (HSPA9), is a mitochondrial matrix chaperone belonging to the Hsp70 family[1][4][16]. GRP75 plays a pivotal role in mitochondrial protein import, folding, and quality control, as well as serving as a molecular bridge facilitating Ca2+ transfer between the endoplasmic reticulum (ER) and mitochondria by linking the IP3R (ER) and VDAC1 (mitochondrial membrane)[2][7][9][13]. It is highly induced by cellular stresses such as glucose deprivation, hypoxia, and oxidative insults. GRP75 extensively regulates mitochondrial function, influences cell proliferation, senescence, metabolic reprogramming, and stress resistance, and is implicated in cancer development, progression, and therapeutic resistance[3][4][6][14]. Altered GRP75 function or expression is also associated with neurodegenerative and cardiovascular diseases via mitochondrial dysfunction[2][9][14]. Clinically, GRP75 has emerged as an anticancer therapeutic target and a potential biomarker for drug resistance, but therapeutic modulation must account for its essential physiological roles to minimize adverse effects[9].
Chaperone inhibition: Disrupts ER–mitochondria crosstalk and calcium transfer by inhibiting GRP75, protecting against oxidative stress[2][7][9]; Anti-proliferative and pro-apoptotic effect via abrogation of GRP75-mediated cytoprotection (MKT-077, JX57)[2][12]; Sensitization to chemotherapeutics by inhibiting stress and survival functions (reducing cisplatin resistance)[3][6]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose-regulated protein 75 (also known as Mortalin) (GRP75).